Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - topiramate, quantity: 25 mg - tablet, film coated - excipient ingredients: hyprolose; croscarmellose sodium; hypromellose; colloidal anhydrous silica; titanium dioxide; magnesium stearate; methylcellulose; macrogol 8000 - epilepsy. adults and children 2 years and over: as monotherapy in patients with newly diagnosed epilepsy; for conversion to monotherapy in patients with epilepsy; as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine. prophylaxis of migraine headache in adults.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - topiramate 25mg;   - film coated tablet - 25 mg - active: topiramate 25mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose opadry white 85f18422 pregelatinised maize starch - topiramate actavis is indicated in adults and children. topiramate actavis tablet range is not suitable for any children weighing less than 25 kg and is not suitable as monotherapy for children or adolescents weighing less than 50 kg. - as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - topiramate, quantity: 200 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; macrogol 8000; titanium dioxide; magnesium stearate; iron oxide red; colloidal anhydrous silica; methylcellulose; hyprolose; hypromellose - epilepsy. adults and children 2 years and over: as monotherapy in patients with newly diagnosed epilepsy; for conversion to monotherapy in patients with epilepsy; as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine. prophylaxis of migraine headache in adults.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - topiramate, quantity: 100 mg - tablet, film coated - excipient ingredients: titanium dioxide; iron oxide yellow; hypromellose; colloidal anhydrous silica; magnesium stearate; macrogol 8000; croscarmellose sodium; methylcellulose; hyprolose - epilepsy. adults and children 2 years and over: as monotherapy in patients with newly diagnosed epilepsy; for conversion to monotherapy in patients with epilepsy; as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine. prophylaxis of migraine headache in adults.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - topiramate, quantity: 50 mg - tablet, film coated - excipient ingredients: iron oxide yellow; hyprolose; hypromellose; methylcellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; colloidal anhydrous silica; macrogol 8000 - epilepsy. adults and children 2 years and over: as monotherapy in patients with newly diagnosed epilepsy; for conversion to monotherapy in patients with epilepsy; as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine. prophylaxis of migraine headache in adults.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

apotex nz ltd - topiramate 25mg;   - tablet - 25 mg - active: topiramate 25mg   excipient: colloidal silicon dioxide croscarmellose sodium hyprolose hypromellose macrogol 8000 magnesium stearate methylcellulose titanium dioxide - apo-topiramate is indicated in adults and children, 2 years and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

actavis new zealand limited - topiramate 25mg - capsule - 25 mg - active: topiramate 25mg excipient: aniseed ethanol gelatin magnesium stearate opadry white 85f18378 povidone purified water saccharin sodium sugar spheres tekprint black sw-9008 titanium dioxide - arrow - topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - topiramate - oral tablet - 25mg

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - topiramate - oral tablet - 25mg

Kanada - angličtina - Health Canada

teva canada limited - topiramate - tablet - 25mg - topiramate 25mg - miscellaneous anticonvulsants